Publicacións nas que colabora con Juan Francisco Merino Torres (8)

2024

  1. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

    Diabetes and Metabolism, Vol. 50, Núm. 1

2023

  1. Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study

    Frontiers in Endocrinology, Vol. 14

2022

  1. Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study

    Drugs in Context, Vol. 11

2021

  1. Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 4, pp. 270-276

2020

  1. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus

    BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1

2018

  1. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529

2013

  1. Evaluación y manejo de la hipoglucemia en el paciente con diabetes mellitus. Documento de posicionamiento: grupo de Trabajo de Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 60, Núm. 9, pp. 1101-1118

2004

  1. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA)

    European Journal of Endocrinology, Vol. 151, Núm. 4, pp. 439-446